Back to Search Start Over

Estrogen-receptor status determines differential regulation of α1- and α2-adrenoceptor-mediated cell survival, angiogenesis, and intracellular signaling responses in breast cancer cell lines.

Authors :
Priyanka HP
Pratap UP
Nair RS
Vasantharekha R
ThyagaRajan S
Source :
Medical oncology (Northwood, London, England) [Med Oncol] 2024 Mar 25; Vol. 41 (5), pp. 92. Date of Electronic Publication: 2024 Mar 25.
Publication Year :
2024

Abstract

Psychosocial stress promotes cancer pathogenesis involving angiogenesis through alterations in neuroendocrine-immune functions that may involve adrenoceptor (AR)-dependent signaling mechanisms in the brain, lymphoid organs, and cancerous cells. Various concentrations of α <subscript>1</subscript> - and α <subscript>2</subscript> - AR-specific agonists and antagonists were incubated in vitro with estrogen receptor-positive (ER +) MCF-7, and ER (-) MDA MB-231 cells to examine the secretions of VEGF-A, VEGF-C, and nitric oxide (NO), and expression of signaling molecules- p-ERK, p-CREB, and p-Akt on the proliferation of breast cancer cell lines. Cellular proliferation, VEGF-A and NO secretion, expression of p-ERK, p-CREB, and p-Akt were enhanced in MCF-7 cells treated with α <subscript>1</subscript> -AR agonist while VEGF-C secretion alone was enhanced in MDA MB-231 cells. Treatment of MCF-7 and MDA MB-231 cells with α <subscript>2</subscript> - AR agonist similarly enhanced proliferation and decreased NO production and p-CREB expression while VEGF-C secretion was decreased in MCF-7 cells and p-Akt expression was decreased in MDA MB-231 cells. α <subscript>1</subscript> -AR inhibition reversed cellular proliferation and VEGF-A secretion by MCF-7 cells while α <subscript>2</subscript> -AR inhibition reversed the proliferation of MCF-7 and MDA MB-231 cells and VEGF-C secretion by MCF-7 cells. Taken together, breast cancer pathogenesis may be influenced by distinct α-AR-mediated signaling mechanisms on angiogenesis and lymphangiogenesis that are dependent on estrogen receptor status.<br /> (© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.)

Details

Language :
English
ISSN :
1559-131X
Volume :
41
Issue :
5
Database :
MEDLINE
Journal :
Medical oncology (Northwood, London, England)
Publication Type :
Academic Journal
Accession number :
38526769
Full Text :
https://doi.org/10.1007/s12032-024-02322-8